So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

More than 4,000 babies were born with HIV in 2023 in Kenya, despite the availability of free medication aimed at preventing mother-to-child transmission. Still, two out of every ten of these children ...

Breakthrough innovations have come to light that have proved to be more than 95% effective in preventing HIV infection with injections just twice a year. Once a year might even be possible. They could ...

Concerns continue to grow as Kenya faces potential ARV stockout, with five months of supplies remaining.Experts fear that ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Health Care Advocates International is a nonprofit whose mission is to end the stigma against people with HIV and AIDS.

Scientists have unveiled insights into how HIV-1, the virus responsible for AIDS, skillfully hijacks cellular machinery for its own survival. By dissecting the molecular interplay between the virus ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

It noted that it was "a pivotal step toward diminishing HIV/AIDS as a global health crisis." The introduction of lenacapavir is potentially a major step forward in the treatment of HIV/AIDS globally.

NEW DELHI: In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an injectable HIV drug. This drug protects people for six ...

Elena Vaughan received funding from the Irish Research Council for her research on HIV stigma in Irish healthcare settings. Speaking at the 16th International Aids Conference in 2006, the then ...